Mylan Pharmaceuticals Inc recalls Acamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx only, Mylan Pharmaceuticals Inc., Manufact
Recalled August 26, 2026 · FDA recall D-0774-2026 · Mylan Pharmaceuticals
Hazard
Failed Dissolution Specifications · FDA Class II
Sold at
US Nationwide.
Description
Failed Dissolution Specifications
Product
Acamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx only, Mylan Pharmaceuticals Inc., Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 266505, NDC 0378-6333-80.
Manufacturer(s)
Mylan Pharmaceuticals Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →